Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.
Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator.
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Immvira’s scientific objectives are based on numerous experimental designs of oHSV and outcomes of clinical trials.
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
Dami&Xiaomi is a child autism intervention agency.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
MiroBio is Harnessing the natural control mechanisms of the immune system.
Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
Laekna Therapeutics is a biotech company focusing on drug discovery and development.
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
MDClone offers a powerful, self-service data analytics environment enabling healthcare collaboration, research, and innovation.
HanBio Therapeutics is a biotechnology company committed to researching and developing next generation transformative medicines.
Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
Edge Medical Robotics is a surgical robot platform company focused on design, R&D, and commercialization of advance medical devices.
PierianDx is catalyzing global adoption of genomic sequencing in healthcare
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
A private biopharmaceutical company .
OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 19 different industry categories.
Among tracked funding rounds, ACELYRIN received $300.0M in a Series C round. OrbiMed's total known invested capital is $23.6B.
OrbiMed's average investment size is $104.0M across its portfolio of 289 companies.
Recent OrbiMed portfolio additions include Aeglea BioTherapeutics, Upstream Bio, Stemirna, Ikena Oncology, Amolyt Pharma. These companies were founded in 2020 or later.